Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$6.05 - $9.28 $20,654 - $31,681
3,414 New
3,414 $20,000
Q2 2022

Jul 25, 2022

SELL
$2.7 - $7.07 $2.47 Million - $6.48 Million
-916,438 Reduced 93.31%
65,716 $294,000
Q1 2022

May 02, 2022

SELL
$4.54 - $16.1 $81,924 - $290,524
-18,045 Reduced 1.8%
982,154 $5.24 Million
Q4 2021

Jan 28, 2022

BUY
$12.01 - $20.3 $12 Million - $20.3 Million
1,000,199 New
1,000,199 $14.7 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.